Preferred Label : Regenerative Medical Therapy;
NCIt related terms : regenerative medicine therapy (RMT);
NCIt definition : A treatment to repair or replace damaged cells, tissues, or organs, including cell
therapies, therapeutic tissue engineering products, human cell and tissue products,
and combination products using any such therapies or products. (https://www.sciencedirect.com/topics/engineering/regenerative-medicine
and http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm);
Alternative definition : CDISC-GLOSS: A treatment to repair or replace damaged cells, tissues, or organs, including
cell therapies, therapeutic tissue engineering products, human cell and tissue products,
and combination products using any such therapies or products. NOTE: RMT may include
human gene therapies, genetically modified cells that lead to a sustained effect on
cells or tissues, xenogeneic cell products, and any combination product where the
biological product constituent part is a regenerative medicine therapy (biologic-device,
biologic-drug, or biologic device-drug). [After S.H.Park, et al. In Situ Tissue Regeneration:
Host Cell Recruitment and Biomaterial Design. Chapter 12. 2016; https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/resources-related-regenerative-medicine-therapies]
See also regenerative medicine, regenerative medicine advanced therapy (RMAT) designation,
cell therapy, gene therapy.;
NCI Metathesaurus CUI : CL979055;
Origin ID : C165833;
UMLS CUI : C5237474;
Semantic type(s)
- concept_is_in_subset
